Hormonal determinants of nipple aspirate fluid yield among breast cancer cases and screening controls

Cancer Epidemiology Biomarkers and Prevention

Volumn 22, Issue 12, 2013, Pages 2277-2284

  Fought, Angela J ^a   McGathey, Claire ^a   Scholtens, Denise M ^a   Heinz, Richard E ^a   Lowe, Rick ^a   Feeney, Yvonne B ^a   Lee, Oukseub ^a   Kmiecik, Thomas E ^a   Wolfman, Judith A ^a   Clevenger, Charles V ^a   Gann, Peter H ^b   Gapstur, Susan ^c   Chatterton, Robert T ^a   Khan, Seema A ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c AMERICAN CANCER SOCIETY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CHORIONIC GONADOTROPIN; ESTRADIOL; FOLLITROPIN; LUTEINIZING HORMONE; PROGESTERONE; PROLACTIN; SEX HORMONE BINDING GLOBULIN;

ADULT; ARTICLE; BREAST CANCER; CANCER SCREENING; CONFIDENCE INTERVAL; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; LACTATION; LOGISTIC REGRESSION ANALYSIS; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MENSTRUAL CYCLE; NIPPLE ASPIRATION; PARITY; PREMENOPAUSE; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; PROLACTIN BLOOD LEVEL; RANK SUM TEST;

ADULT; AGED; BREAST NEOPLASMS; CASE-CONTROL STUDIES; EARLY DETECTION OF CANCER; FEMALE; HORMONES; HUMANS; MIDDLE AGED; NIPPLE ASPIRATE FLUID;

EID: 84890031902     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-12-0434     Document Type: Article

References (25)

1. Chatterton RT Jr, Geiger AS, Khan SA, Helenowski IB, Jovanovic BD, Gann PH. Variation in estradiol, estradiol precursors, and estrogenrelated products in nipple aspirate fluid from normal premenopausal women. Cancer Epidemiol Biomarkers Prev 2004;13:928-35.
2. Papanicolaou GN, Holmquist DG, Bader GM, Falk EA. Exfoliative cytology of the human mammary gland and its value in the diagnosis of cancer and other diseases of the breast. Cancer 1958;11:377-409.
3. Sartorius OW, Smith HS, Morris P, Benedict D, Friesen L. Cytologic evaluation of breast fluid in the detection of breast disease. J Natl Cancer Inst 1977;59:1073-80.
4. King EB, Chew KL, Petrakis NL, Ernster VL. Nipple aspirate cytology for the study of breast cancer precursors. J Natl Cancer Inst 1983;71: 1115-21.
5. Wrensch MR, Petrakis NL, Miike R, King EB, Chew K, Neuhaus J, et al. Breast cancer risk in women with abnormal cytology in nipple aspirates of breast fluid. J Natl Cancer Inst 2001;93:1791-8.
6. Sauter ER, Ross E, Daly M, Klein-Szanto A, Engstrom PH, Sorling A, et al. Nipple aspirate fluid: a promising non-invasive method to identify cellular markers of breast cancer risk. Br J Cancer 1997;76:494-501.
7. Sauter ER, Shan S, Hewett JE, Speckman P, Du Bois GC. Proteomic analysis of nipple aspirate fluid using SELDI-TOF-MS. Int J Cancer 2005;114:791-6.
8. Khan SA, Chatterton RT Jr. Cellular and hormonal content of breast nipple aspirate fluid in relation to the risk of breast cancer. Biomark Med 2008;2:479-93.
9. Gann PH, Geiger AS, Helenowski IB, Vonesh EF, Chatterton RT. Estrogen and progesterone levels in nipple aspirate fluid of healthy premenopausal women: relationship to steroid precursors and response proteins. Cancer Epidemiol Biomarkers Prev 2006;15:39-44.
10. Zhao Y, Verselis SJ, Klar N, Sadowsky NL, Kaelin CM, Smith B, et al. Nipple fluid carcinoembryonic antigen and prostate-specific antigen in cancer-bearing and tumor-free breasts. J Clin Oncol 2001;19:1462-7.
11. Wrensch MR, Petrakis NL, Gruenke LD, Ernster VL, Miike R, King EB, et al. Factors associated with obtaining nipple aspirate fluid: analysis of 1428 women and literature review. Breast Cancer Res Treat 1990;15: 39-51.
12. Wrensch MR, Petrakis NL, King EB, Miike R, Mason L, Chew KL, et al. Breast cancer incidence in women with abnormal cytology in nipple aspirates of breast fluid. Am J Epidemiol 1992;135:130-41.
13. Gout PW, Beer CT, Noble RL. Prolactin-stimulated growth of cell cultures established from malignant Nb rat lymphomas. Cancer Res 1980;40:2433-6.
14. Rinaldi S, Geay A, Dechaud H, Biessy C, Zeleniuch-Jacquotte A, Akhmedkhanov A, et al. Validity of free testosterone and free estradiol determinations in serum samples from postmenopausal women by theoretical calculations. Cancer Epidemiol Biomarkers Prev 2002;11: 1065-71.
15. Byng JW, Yaffe MJ, Jong RA, Shumak RS, Lockwood GA, Tritchler DL, et al. Analysis of mammographic density and breast cancer risk from digitized mammograms. Radiographics 1998;18: 1587-98.
16. Sarac F, Tutuncuoglu P, Ozgen AG, Saygili F, Yilmaz C, Bilgen I, et al. Prolactin levels and examination with breast ultrasound or mammography. Adv Ther 2008;25:59-66.
17. Nyante SJ, Faupel-Badger JM, Sherman ME, Pfeiffer RM, Gaudet MM, Falk RT, et al. Genetic variation in PRL and PRLR, and relationships with serum prolactin levels and breast cancer risk: results from a population-based case-control study in Poland. Breast Cancer Res 2011;13:R42.
18. Tworoger SS, Hankinson SE. Prolactin and breast cancer etiology: an epidemiologic perspective. J Mammary Gland Biol Neoplasia 2008;13: 41-53.
19. Tworoger SS, Eliassen AH, Sluss P, Hankinson SE. A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer. J Clin Oncol 2007;25: 1482-8.
20. Clevenger CV, Gadd SL, Zheng J. New mechanisms for PRLr action in breast cancer 1. Trends Endocrinol Metab 2009;20:223-9.
21. Clevenger CV, Furth PA, Hankinson SE, Schuler LA. The role of prolactin in mammary carcinoma 3. Endocr Rev 2003;24:1-27.
22. Hill PD, Chatterton RT Jr, Aldag JC. Serum prolactin in breastfeeding: state of the science 1. Biol Res Nurs 1999;1:65-75.
23. Fujimoto VY, Clifton DK, Cohen NL, Soules MR. Variability of serum prolactin and progesterone levels in normal women: the relevance of single hormone measurements in the clinical setting. Obstet Gynecol 1990;76:71-8.
24. Nagata C, Wada K, Nakamura K, Hayashi M, Takeda N, Yasuda K, et al. Associations of body size and reproductive factors with circulating levels of sex hormones and prolactin in premenopausal Japanese women. Cancer Causes Control 2011;22:581-8.
25. Dooley WC, Ljung B-M, Veronesi U, Cazzaniga M, Elledge RM, O'Shaughnessy JA, et al. Ductal lavage for detection of cellular atypia in women at high risk for breast cancer. J Natl Cancer Inst 2001;93: 1624-32.